Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1998 Dec 1;17(23):6812–6818. doi: 10.1093/emboj/17.23.6812

Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.

A Jasanoff 1, G Wagner 1, D C Wiley 1
PMCID: PMC1171028  PMID: 9843486

Abstract

The invariant chain (Ii) plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alphabeta heterodimers in a nonameric (alphabetaIi)3 complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to compartments where peptide loading of class II takes place. Loading progresses following Ii proteolysis and via an intermediate complex of MHC class II with an Ii-derived peptide, CLIP. CLIP is substituted by exogenous peptidic fragments in an exchange reaction catalyzed by HLA-DM. The CLIP region of Ii, roughly residues 81-104, is one of two segments shown to interact with class II HLA-DR molecules. The other segment, Ii 118-216, is C-terminal to CLIP, mediates trimerization of the ectodomain of Ii and interferes with DM/class II binding. Here we report the three-dimensional structure of this trimeric domain, determined by nuclear magnetic resonance (NMR) studies of a 27 kDa trimer of human Ii 118-192. The cylindrical shape of the molecule and the mapping of conserved residues delimit surfaces which may be important for interactions between Ii and class II molecules.

Full Text

The Full Text of this article is available as a PDF (434.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertolino P., Staschewski M., Trescol-Biémont M. C., Freisewinkel I. M., Schenck K., Chrétien I., Forquet F., Gerlier D., Rabourdin-Combe C., Koch N. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. J Immunol. 1995 Jun 1;154(11):5620–5629. [PubMed] [Google Scholar]
  2. Bevec T., Stoka V., Pungercic G., Dolenc I., Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med. 1996 Apr 1;183(4):1331–1338. doi: 10.1084/jem.183.4.1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bijlmakers M. J., Benaroch P., Ploegh H. L. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J Exp Med. 1994 Aug 1;180(2):623–629. doi: 10.1084/jem.180.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Denzin L. K., Hammond C., Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med. 1996 Dec 1;184(6):2153–2165. doi: 10.1084/jem.184.6.2153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Freisewinkel I. M., Schenck K., Koch N. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9703–9706. doi: 10.1073/pnas.90.20.9703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gedde-Dahl M., Freisewinkel I., Staschewski M., Schenck K., Koch N., Bakke O. Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J Biol Chem. 1997 Mar 28;272(13):8281–8287. doi: 10.1074/jbc.272.13.8281. [DOI] [PubMed] [Google Scholar]
  7. Ghosh P., Amaya M., Mellins E., Wiley D. C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 1995 Nov 30;378(6556):457–462. doi: 10.1038/378457a0. [DOI] [PubMed] [Google Scholar]
  8. Holm L., Sander C. Dali: a network tool for protein structure comparison. Trends Biochem Sci. 1995 Nov;20(11):478–480. doi: 10.1016/s0968-0004(00)89105-7. [DOI] [PubMed] [Google Scholar]
  9. Jasanoff A. An asymmetric deuterium labeling strategy to identify interprotomer and intraprotomer NOEs in oligomeric proteins. J Biomol NMR. 1998 Aug;12(2):299–306. doi: 10.1023/a:1008285512845. [DOI] [PubMed] [Google Scholar]
  10. Jasanoff A., Park S. J., Wiley D. C. Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9900–9904. doi: 10.1073/pnas.92.21.9900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karp D. R., Jenkins R. N., Long E. O. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9657–9661. doi: 10.1073/pnas.89.20.9657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kim J., Urban R. G., Strominger J. L., Wiley D. C. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science. 1994 Dec 16;266(5192):1870–1874. doi: 10.1126/science.7997880. [DOI] [PubMed] [Google Scholar]
  13. Koch N., Lauer W., Habicht J., Dobberstein B. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 1987 Jun;6(6):1677–1683. doi: 10.1002/j.1460-2075.1987.tb02417.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Machamer C. E., Cresswell P. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J Immunol. 1982 Dec;129(6):2564–2569. [PubMed] [Google Scholar]
  15. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991;11(4):281–296. doi: 10.1002/prot.340110407. [DOI] [PubMed] [Google Scholar]
  16. Nilges M. A calculation strategy for the structure determination of symmetric dimers by 1H NMR. Proteins. 1993 Nov;17(3):297–309. doi: 10.1002/prot.340170307. [DOI] [PubMed] [Google Scholar]
  17. Park S. J., Sadegh-Nasseri S., Wiley D. C. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11289–11293. doi: 10.1073/pnas.92.24.11289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Roche P. A., Marks M. S., Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature. 1991 Dec 5;354(6352):392–394. doi: 10.1038/354392a0. [DOI] [PubMed] [Google Scholar]
  19. Romagnoli P., Germain R. N. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med. 1994 Sep 1;180(3):1107–1113. doi: 10.1084/jem.180.3.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES